Chongqing Zhifei Biological Products Co., Ltd. (SHE: 300122)

Chongqing Zhifei Biological Products Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	5,586	6,341	2,622	4,308	1,437	1,150
Cash & Short-Term Investments	5,586	6,341	2,622	4,308	1,437	1,150
Cash Growth	-	141.81%	-39.13%	199.68%	24.98%	49.48%
Accounts Receivable	25,472	27,059	20,614	12,868	6,624	4,437
Other Receivables	8.02	7.8	8.39	6.87	9.07	63.09
Receivables	25,480	27,066	20,622	12,874	6,633	4,500
Inventory	15,653	8,986	8,020	7,385	3,406	2,484
Prepaid Expenses	0	-	-	0.59	5.04	-
Other Current Assets	92.74	121.11	148.53	185.63	55.67	31.44
Total Current Assets	46,812	42,514	31,413	24,754	11,537	8,167
Property, Plant & Equipment	5,105	5,120	4,693	3,557	2,387	1,984
Long-Term Investments	295	295	284.5	239	170	100
Goodwill	19.28	19.28	19.28	19.28	19.28	19.28
Other Intangible Assets	304.93	317.68	352.71	342.8	270.53	240.86
Long-Term Deferred Tax Assets	754.6	569.19	186.08	115.34	124.16	74.4
Long-Term Deferred Charges	1,200	1,088	731.97	485.04	402.79	240.66
Other Long-Term Assets	353.54	308.42	322.5	534.91	304.82	116.8
Total Assets	54,845	50,232	38,004	30,047	15,215	10,942
Accounts Payable	16,338	13,142	9,807	9,178	3,084	2,223
Accrued Expenses	628.51	1,673	1,240	1,090	501.54	353.37
Short-Term Debt	3,442	2,635	1,785	568.86	2,874	2,384
Current Portion of Long-Term Debt	48.61	36.41	-	-	-	-
Current Portion of Leases	12.64	10.2	9.81	0.25	-	-
Current Income Taxes Payable	218.15	434.59	347.7	933.25	323.7	98.18
Current Unearned Revenue	5.57	11.31	-	-	-	-
Other Current Liabilities	1,959	143.86	40.17	99.62	32.88	13.99
Total Current Liabilities	22,653	18,086	13,230	11,871	6,817	5,072
Long-Term Debt	379.08	328.08	210.64	236.41	-	-
Long-Term Leases	19.08	25.31	27.76	12.24	-	-
Long-Term Unearned Revenue	215.36	228.27	238.34	222.2	115.84	94.66
Long-Term Deferred Tax Liabilities	53.75	57.96	60.77	48.34	29.88	24.65
Other Long-Term Liabilities	-	-	-	-	4.35	3.77
Total Liabilities	23,320	18,726	13,768	12,390	6,967	5,195
Common Stock	2,394	2,400	1,600	1,600	1,600	1,600
Additional Paid-In Capital	-	47.96	207.96	207.96	207.96	207.96
Retained Earnings	29,132	29,058	22,428	15,849	6,441	3,939
Shareholders' Equity	31,525	31,506	24,236	17,657	8,249	5,747
Total Liabilities & Equity	54,845	50,232	38,004	30,047	15,215	10,942
Total Debt	3,902	3,035	2,033	817.76	2,874	2,384
Net Cash (Debt)	1,685	3,305	588.94	3,490	-1,437	-1,234
Net Cash Growth	-	461.19%	-83.13%	-	-	-
Net Cash Per Share	0.70	1.38	0.25	1.45	-0.60	-0.51
Filing Date Shares Outstanding	2,394	2,400	2,400	2,400	2,400	2,400
Total Common Shares Outstanding	2,394	2,400	2,400	2,400	2,400	2,400
Working Capital	24,160	24,428	18,183	12,883	4,720	3,095
Book Value Per Share	13.17	13.13	10.10	7.36	3.44	2.39
Tangible Book Value	31,201	31,169	23,864	17,295	7,959	5,487
Tangible Book Value Per Share	13.03	12.99	9.94	7.21	3.32	2.29
Buildings	2,541	2,522	1,705	1,042	1,014	696.29
Machinery	2,594	2,526	2,064	1,369	904.94	669.55
Construction In Progress	1,370	1,287	1,836	1,825	906.49	947.11

Source: S&P Capital IQ. Standard template. Financial Sources.